Savior Lifetec Corporation (4167.TWO)
TWD 17.9
(6.23%)
TWD 17.9
(6.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 219.6 Million TWD | -16.53% |
| 2022 | 260.72 Million TWD | -0.99% |
| 2021 | 263.32 Million TWD | -48.23% |
| 2020 | 508.65 Million TWD | 105.51% |
| 2019 | 247.5 Million TWD | 272.17% |
| 2018 | -135.49 Million TWD | -157.06% |
| 2017 | 251.94 Million TWD | 608.64% |
| 2016 | 35.55 Million TWD | 113.65% |
| 2015 | -260.47 Million TWD | -51.79% |
| 2014 | -171.6 Million TWD | -82.87% |
| 2013 | -96.39 Million TWD | 69.12% |
| 2012 | -301.83 Million TWD | -167.81% |
| 2011 | -114.93 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 61.53 Million TWD | -44.04% |
| 2024 Q1 | 109.46 Million TWD | 26.34% |
| 2023 Q3 | 28 Million TWD | -49.81% |
| 2023 Q4 | 86.24 Million TWD | 207.94% |
| 2023 FY | - TWD | -16.53% |
| 2023 Q1 | 47.58 Million TWD | 302.82% |
| 2023 Q2 | 55.79 Million TWD | 17.27% |
| 2022 FY | - TWD | -0.99% |
| 2022 Q4 | 11.81 Million TWD | -93.71% |
| 2022 Q2 | 56.94 Million TWD | 1220.33% |
| 2022 Q3 | 187.65 Million TWD | 229.53% |
| 2022 Q1 | 4.31 Million TWD | -84.11% |
| 2021 Q3 | 5 Million TWD | -94.25% |
| 2021 Q1 | 144.14 Million TWD | -9.01% |
| 2021 FY | - TWD | -48.23% |
| 2021 Q2 | 87.03 Million TWD | -39.62% |
| 2021 Q4 | 27.15 Million TWD | 442.37% |
| 2020 FY | - TWD | 105.51% |
| 2020 Q3 | 109.11 Million TWD | 36.29% |
| 2020 Q2 | 80.06 Million TWD | -50.29% |
| 2020 Q1 | 161.06 Million TWD | 64.71% |
| 2020 Q4 | 158.41 Million TWD | 45.18% |
| 2019 Q2 | 35.82 Million TWD | -23.61% |
| 2019 Q4 | 97.78 Million TWD | 45.95% |
| 2019 Q3 | 67 Million TWD | 87.05% |
| 2019 FY | - TWD | 272.17% |
| 2019 Q1 | 46.89 Million TWD | 180.51% |
| 2018 FY | - TWD | -157.06% |
| 2018 Q4 | -58.24 Million TWD | -48.5% |
| 2018 Q3 | -39.22 Million TWD | -1016.16% |
| 2018 Q2 | 4.28 Million TWD | 108.47% |
| 2018 Q1 | -50.57 Million TWD | -1496.22% |
| 2017 FY | - TWD | 608.64% |
| 2017 Q3 | 73.35 Million TWD | -31.05% |
| 2017 Q1 | 68.59 Million TWD | -13.97% |
| 2017 Q2 | 106.38 Million TWD | 55.1% |
| 2017 Q4 | 3.62 Million TWD | -95.06% |
| 2016 Q4 | 79.73 Million TWD | 698.04% |
| 2016 FY | - TWD | 113.65% |
| 2016 Q1 | -56.17 Million TWD | 46.24% |
| 2016 Q3 | 9.99 Million TWD | 399.05% |
| 2016 Q2 | 2 Million TWD | 103.56% |
| 2015 Q4 | -104.49 Million TWD | -87.06% |
| 2015 Q3 | -55.86 Million TWD | -32.97% |
| 2015 FY | - TWD | -51.79% |
| 2015 Q2 | -42.01 Million TWD | 27.7% |
| 2015 Q1 | -58.1 Million TWD | 37.03% |
| 2014 Q3 | -60.17 Million TWD | -238.06% |
| 2014 FY | - TWD | -82.87% |
| 2014 Q4 | -92.27 Million TWD | -53.36% |
| 2014 Q2 | -17.79 Million TWD | 54.34% |
| 2014 Q1 | -38.98 Million TWD | 11.31% |
| 2013 Q1 | -15.43 Million TWD | 79.09% |
| 2013 Q4 | -43.95 Million TWD | -250.98% |
| 2013 FY | - TWD | 69.12% |
| 2013 Q3 | -12.52 Million TWD | 18.89% |
| 2013 Q2 | -15.43 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | - TWD | -167.81% |
| 2012 Q4 | -73.84 Million TWD | 0.0% |
| 2012 Q3 | -73.84 Million TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 44.207% |
| Level Biotechnology Inc. | 98.7 Million TWD | -122.488% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 590.858% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 404.521% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 252.827% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 311.943% |
| Visgeneer Inc. | 973 Thousand TWD | -22469.887% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 76.55% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | -119.964% |
| Neith Corporation | -33.61 Million TWD | 753.392% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 12742.775% |
| Enimmune corporation | -228.96 Million TWD | 195.913% |
| TaiRx, Inc. | -208.64 Million TWD | 205.252% |
| EirGenix Inc. | -664.4 Million TWD | 133.053% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | -197.149% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | -217.61% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 374.259% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 294.159% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -530.361% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 935.0% |
| RBC Bioscience Corporation | 36.54 Million TWD | -500.884% |
| BiOptic Inc. | 65.03 Million TWD | -237.656% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 574.883% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 765.349% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 499.9% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 49.348% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 164.688% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 122.158% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 452.264% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 970.309% |
| GlycoNex Incorporation | -126.82 Million TWD | 273.153% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -906.901% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 1338.886% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 120.497% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 132.178% |
| VBI | -6.97 Million TWD | 3249.814% |
| CHO Pharma, Inc. | -277.73 Million TWD | 179.071% |
| NaviFUS Corp. | -55.79 Million TWD | 493.593% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 1423.081% |
| Sinew Pharma Inc. | -163.63 Million TWD | 234.207% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 457.081% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | -14.139% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 196.88% |
| AP Biosciences Inc | -325.51 Million TWD | 167.464% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 121.023% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 712.635% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -653.879% |
| Intech Biopharm Corporation | -219.58 Million TWD | 200.009% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 132.571% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 588.543% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 236.522% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 66.499% |
| TCI GENE Inc. | 25.98 Million TWD | -745.252% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 298.49% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 177.384% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 250.445% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -1485.596% |
| PharmaEngine, Inc. | 347.3 Million TWD | 36.769% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | -27.507% |
| OBI Pharma, Inc. | -855.08 Million TWD | 125.682% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 337.249% |
| Acepodia, Inc. | -764.51 Million TWD | 128.725% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 147.731% |